Patents Assigned to GNT PHARMA CO., LTD.
  • Patent number: 11826329
    Abstract: The present invention relates to pharmaceutical compositions and methods for treating ischemic stroke in humans, using a tetrafluorobenzyl derivative of formula (I) or a pharmaceutically acceptable salt thereof conjointly with a thrombolytic drug, endovascular thrombectomy, or both (e.g., endovascular thrombectomy and a thrombolytic drug). Administration of a tetrafluorobenzyl derivative of formula (I) or its pharmaceutically acceptable salt can reduce reperfusion injury and other adverse events in patients conjointly receiving a thrombolytic drug, endovascular thrombectomy, or endovascular thrombectomy with a thrombolytic drug.
    Type: Grant
    Filed: March 10, 2021
    Date of Patent: November 28, 2023
    Assignee: GNT Pharma Co., Ltd.
    Inventors: Byoung Joo Gwag, Chun San An, Jing Yu Jin, Sung Ig Cho, Fangmeng Zhu, Xinliang Xu, Weiqiang Zhan, Fuxin Liu, Soon-Mi Won
  • Publication number: 20220249343
    Abstract: The present invention relates to a composition comprising: a 5-benzyl aminosalicylic acid compound in chemical formula I or cosmetically acceptable salts thereof; and a cosmetically acceptable excipient suitable for local administration. The composition comprising the 5-benzyl aminosalicylic acid compound in chemical formula I or cosmetically acceptable salts thereof can be used for reducing or alleviating human skin aging by means of antioxidant, anti-inflammatory and whitening actions on the skin.
    Type: Application
    Filed: July 8, 2020
    Publication date: August 11, 2022
    Applicant: GNT PHARMA CO., LTD.
    Inventors: Jin Hee SHIN, Byoung Joo GWAG, Soon Mi WON